Evaluating soluble Axl as a biomarker for glioblastoma: a pilot study | medRxiv

Article usage

Article usage: March 2024 to November 2024

	Abstract	Full	Pdf
Mar 2024	175	12	32
Apr 2024	69	6	7
May 2024	36	6	12
Jun 2024	15	3	1
Jul 2024	28	2	10
Aug 2024	25	10	9
Sep 2024	12	4	7
Oct 2024	10	6	6
Nov 2024	8	4	7

View the discussion thread.

Posted March 26, 2024.

Subject Area

Oncology

Subject Areas

All Articles

Addiction Medicine (393)
Allergy and Immunology (705)
Anesthesia (197)
Cardiovascular Medicine (2882)
Dentistry and Oral Medicine (327)
Dermatology (247)
Emergency Medicine (432)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1019)
Epidemiology (12622)
Forensic Medicine (10)
Gastroenterology (813)
Genetic and Genomic Medicine (4483)
Geriatric Medicine (409)
Health Economics (717)
Health Informatics (2868)
Health Policy (1059)
Health Systems and Quality Improvement (1057)
Hematology (379)
HIV/AIDS (911)
Infectious Diseases (except HIV/AIDS) (14031)
Intensive Care and Critical Care Medicine (836)
Medical Education (418)
Medical Ethics (115)
Nephrology (466)
Neurology (4251)
Nursing (228)
Nutrition (622)
Obstetrics and Gynecology (796)
Occupational and Environmental Health (727)
Oncology (2226)
Ophthalmology (634)
Orthopedics (255)
Otolaryngology (323)
Pain Medicine (270)
Palliative Medicine (83)
Pathology (491)
Pediatrics (1182)
Pharmacology and Therapeutics (492)
Primary Care Research (488)
Psychiatry and Clinical Psychology (3696)
Public and Global Health (6829)
Radiology and Imaging (1503)
Rehabilitation Medicine and Physical Therapy (878)
Respiratory Medicine (909)
Rheumatology (431)
Sexual and Reproductive Health (434)
Sports Medicine (376)
Surgery (476)
Toxicology (60)
Transplantation (206)
Urology (176)